What is CorMedix's debt issuance cost amortization?

CorMedix (CRMD) reported debt issuance cost amortization of $99.5K in Q4 2025.

What does debt issuance cost amortization mean?

Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).

CorMedix CRMD Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

Merit Medical SystemsMMSI

$1.41M0.0%

ITG

Integer HoldingsITGR

$1.63M-13.7%

Emergent BiosolutionsEBS

$1.8M-21.7%

ICU MedicalICUI

$774K-54.5%

Mirum Pharmaceuticals, Inc.MIRM

$454K+4.8%

TFX

TeleflexTFX

$1.48M+74.0%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's debt issuance cost amortization?: CorMedix (CRMD) reported debt issuance cost amortization of $99.5K in Q4 2025.
What does debt issuance cost amortization mean?: Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).